Table 2 Frequency of genotypes associated with selected FCN2 single nucleotide gene polymorphisms.

From: Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults

Polymorphism

Genotype

Group

C

AML

AML-A

AML-B

AML-C

AML-D

-64 A > C

A/A

203 (78.7)

126 (80.3)

32 (78)

49 (83.1)

2 (33.3)

43 (84.3)

(rs78654553)

A/C

54 (20.9)

29 (18.5)

9 (22)

9 (15.3)

4 (66.7)

7 (13.7)

C/C

1 (0.4)

2 (1.3)

0

1 (1.7)

0

1 (2)

-4 A > G

A/A

105 (40.9)

66 (42)

12 (29.3)

25 (42.4)

4 (66.7)

25 (49)

(rs17514136)

A/G

118 (45.9)

74 (47.1)

26 (63.4)

24 (40.7)

2 (33.3)

22 (43.1)

G/G

34 (13.2)

17 (10.8)

3 (7.3)

10 (16.9)

0

4 (7.8)

+ 6,359 C > T

C/C

99 (38.8)

69 (43.9)

12 (29.3)1

27 (45.8)

3 (50)

27 (52.9)

(rs175491193)

C/T

115 (45.1)

67 (42.7)

24 (58.5)

21 (35.6)

3 (50)

19 (37.3)

T/T

41 (16.1)

21 (13.4)

5 (12.2)

11 (18.6)

0

5 (9.8)

+ 6,424 G > T

G/G

199 (77.4)

129 (82.2)

35 (85.4)

49 (83.1)

2 (33.3)

43 (84.3)

(rs7851696)

G/T

58 (22.6)

25 (15.9)

6 (14.6)

9 (15.3)

3 (50)

7 (13.7)

T/T

0

3 (1.9)

0

1 (1.7)

1 (16.7)

1 (2)

  1. Percentages are shown in parentheses. Allele distributions were in accordance with Hardy–Weinberg equlibrium.
  2. C: controls; AML-A: patients who experienced infections with proven bacteremia and/or fungaemia; AML-B: patients who experienced infections with no bacteremia; AML-C: patients who experienced febrile neutropenia; AML-D: patients who experienced none of afore-mentioned complications within 4 weeks of hospital stay.
  3. 1p = 0.033, OR = 0.37, 95% CI (0.15–0.88) (vs. AML-D).